http://www.alleanzacontroilcancro.it/impa/ La task-force nazionale contro la contraffazione farmaceutica: Le novità del Sito Gruppo Web ISS (webmaster@iss.it) Gruppo Web ISS (webmaster@iss.it) Mon, 06 Sep 10 07:35:19 +0200 Mon, 06 Sep 10 07:35:19 +0200 60 Istituzioni coinvolte http://www.iss.it/impa/chis/cont.php?id=203&tipo=1&lang=1 Struttura di IMPACT Italia http://www.iss.it/impa/chis/cont.php?id=163&tipo=1&lang=1 Attività di IMPACT Italia http://www.iss.it/impa/chis/cont.php?id=200&tipo=1&lang=1 Istituto Superiore di Sanità - ISS http://www.iss.it/impa/chis/cont.php?id=220&tipo=1&lang=1 http://www.iss.it/impa/chis/cont.php?id=218&tipo=1&lang=1 Agenzia delle Dogane http://www.iss.it/impa/chis/cont.php?id=224&tipo=1&lang=1 Ministero dello Sviluppo Economico http://www.iss.it/impa/chis/cont.php?id=225&tipo=1&lang=1 Ministero della Salute http://www.iss.it/impa/chis/cont.php?id=219&tipo=1&lang=1 Carabinieri NAS http://www.iss.it/impa/chis/cont.php?id=221&tipo=1&lang=1 Ministero dell'Interno - Direzione Centrale della Polizia Criminale http://www.iss.it/impa/chis/cont.php?id=223&tipo=1&lang=1 Che cos'è un farmaco contraffatto http://www.iss.it/impa/faco/cont.php?id=209&tipo=33&lang=1 Pericolosità dei farmaci contraffatti http://www.iss.it/impa/faco/cont.php?id=208&tipo=33&lang=1 Farmacie on line: nuovi mercati, nuovi pericoli http://www.iss.it/impa/faco/cont.php?id=204&tipo=33&lang=1 http://www.iss.it/impa/faco/cont.php?id=207&tipo=33&lang=1 http://www.iss.it/impa/faco/cont.php?id=210&tipo=33&lang=1 http://www.iss.it/impa/faco/cont.php?id=212&tipo=33&lang=1 http://www.iss.it/impa/faco/cont.php?id=213&tipo=33&lang=1 http://www.iss.it/impa/faco/cont.php?id=214&tipo=33&lang=1 http://www.iss.it/impa/faqs/cont.php?id=181&tipo=3&lang=1 http://www.iss.it/impa/faqs/cont.php?id=182&tipo=3&lang=1 http://www.iss.it/impa/faqs/cont.php?id=183&tipo=3&lang=1 http://www.iss.it/impa/faqs/cont.php?id=184&tipo=3&lang=1 http://www.iss.it/impa/faqs/cont.php?id=185&tipo=3&lang=1 http://www.iss.it/impa/faqs/cont.php?id=186&tipo=3&lang=1 http://www.iss.it/impa/faqs/cont.php?id=177&tipo=3&lang=1 http://www.iss.it/impa/faqs/cont.php?id=165&tipo=3&lang=1 http://www.iss.it/impa/faqs/cont.php?id=166&tipo=3&lang=1 http://www.iss.it/impa/faqs/cont.php?id=167&tipo=3&lang=1 http://www.iss.it/impa/faqs/cont.php?id=170&tipo=3&lang=1 http://www.iss.it/impa/espe/cont.php?id=206&tipo=36&lang=1 http://www.iss.it/impa/espe/cont.php?id=197&tipo=36&lang=1 http://www.iss.it/impa/segn/cont.php?id=205&tipo=6&lang=1 http://www.iss.it/impa/segn/cont.php?id=168&tipo=6&lang=1 Counterfeit medicines are a major threat to public health and safety. As counterfeiting methods become more sophisticated the risk that counterfeit medicines enter the EU through illegal distribution channels increases every year. Compared to 2005 seizures of counterfeit medicines at the boarder of the EU have increased in 2007 by 380%. Fake medicines represent a serious threat to global health and call for a comprehensive strategy both at European and at international level. http://www.iss.it/impa/docs/cont.php?id=229&tipo=25&lang=1 Counterfeit medicines and pharmaceutical crime in general are fast upcoming phenomena which directly involve public health and do need a multidisciplinary, multisectorial and cross-border approach. The basic principles of an adequate approach are collaboration and responsibility. Collaboration can be set up ad hoc for isolated cases but should be structured within a network. Within networks, single points of contact (SPOCs) should collaborate to meet the pre-set objectives. http://www.iss.it/impa/docs/cont.php?id=230&tipo=25&lang=1 Council of Europe (2009) - Draft Convention of the Council of Europe on counterfeiting of medical products and similar crimes involving threats to public health http://www.iss.it/impa/docs/cont.php?id=215&tipo=25&lang=1 EDQM (2009) - Farmacie on line: nuovi mercati, nuovi pericoli (da Counterfeit Medicines: Facts and case studies) http://www.iss.it/impa/docs/cont.php?id=216&tipo=25&lang=1 WHO/IMPACT (2008) - Counterfeit drugs kill http://www.iss.it/impa/docs/cont.php?id=222&tipo=25&lang=1 WHO/IMPACT (2008) - International Medical Product Anti-Counterfeiting Taskforce, Third General Meeting http://www.iss.it/impa/docs/cont.php?id=227&tipo=25&lang=1 EDQM (2008) - Model approach “Counterfeit medicines in Europe: risk communication strategies for Drug Regulatory Authorities” http://www.iss.it/impa/docs/cont.php?id=217&tipo=25&lang=1 Council of Europe (2007) - The Quality of medicines in Europe http://www.iss.it/impa/docs/cont.php?id=231&tipo=25&lang=1 AIFA (2007) - Farmaci veri, farmaci falsi. Bollettino d’informazione sui farmaci BIF, XIV n.3 http://www.iss.it/impa/docs/cont.php?id=232&tipo=25&lang=1 Council of Europe (2006) - International Conference – Europe against Counterfeit Medicines, Moscow Declaration http://www.iss.it/impa/docs/cont.php?id=233&tipo=25&lang=1 WHO (2006) - Combating Counterfeit Drugs: Building Effective International Collaboration, Declaration of Rome http://www.iss.it/impa/docs/cont.php?id=234&tipo=25&lang=1 Council of Europe (2004) - Counterfeiting: problems and solutions http://www.iss.it/impa/docs/cont.php?id=235&tipo=25&lang=1 ISS (2002) - Farmaci contraffatti e fattori di rischio, Notiziario dell’Istituto Superiore di Sanità, 15 (10) http://www.iss.it/impa/docs/cont.php?id=236&tipo=25&lang=1 Stampa italiana http://www.iss.it/impa/docs/cont.php?id=202&tipo=25&lang=1 La contraffazione dei prodotti medicinali ed altri crimini farmaceutici correlati mettono in serio pericolo la salute pubblica in Europa e nel mondo intero. http://www.iss.it/impa/docs/cont.php?id=195&tipo=25&lang=1 WHO (1999) - Counterfeit Drugs. Guidelines for the development of measures to combat counterfeit drugs. (WHO/EDM/QSM/99.1), Geneva http://www.iss.it/impa/docs/cont.php?id=172&tipo=25&lang=1 http://www.iss.it/impa/even/cont.php?id=240&tipo=39&lang=1 http://www.iss.it/impa/even/cont.php?id=237&tipo=39&lang=1